TRPM2 and T-cell leukemia: Inhibition of TRPM2 could cause tumor cell death, and promote the tumor drug sensitivity in T cell leukemia, gastric cancer, breast cancer cells, and neuroblastoma, to chemotherapeutic agents [16–19, 21–23].